Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary

被引：0
|
作者：
Esheba, G. E. [1 ]
Pate, L. L. [1 ]
Van De Rijn, M. [1 ]
Longacre, T. A. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
MODERN PATHOLOGY | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
893
引用
收藏
页码：196A / 196A
页数：1
相关论文
共 50 条
  • [31] The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma
    Yamauchi, N
    Watanabe, A
    Hishinuma, M
    Ohashi, K
    Midorikawa, Y
    Morishita, Y
    Niki, T
    Shibahara, J
    Mori, M
    Makuuchi, M
    Hippo, Y
    Kodama, T
    Iwanari, H
    Aburatani, H
    Fukayama, M
    MODERN PATHOLOGY, 2005, 18 (12) : 1591 - 1598
  • [32] Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma
    Aviel-Ronen, Sarit
    Lau, Suzanne K.
    Pintilie, Melania
    Lau, Davina
    Liu, Ni
    Tsao, Ming Sound
    Jothy, Serge
    MODERN PATHOLOGY, 2008, 21 (07) : 817 - 825
  • [33] The use of cytokeratin 7 in differentiating yolk sac tumors from endometrioid and clear cell carcinomas of the ovary
    Ramalingam, P
    Malpica, A
    Silva, EG
    Liu, JL
    Gershenson, DM
    Deavers, MT
    MODERN PATHOLOGY, 2003, 16 (01) : 207A - 207A
  • [34] The use of cytokeratin 7 in differentiating yolk sac tumors from endometrioid and clear cell carcinomas of the ovary
    Ramalingam, P
    Malpica, A
    Silva, EG
    Liu, JL
    Gershenson, DM
    Deavers, MT
    LABORATORY INVESTIGATION, 2003, 83 (01) : 207A - 207A
  • [35] Serum miRNAs as predictive biomarkers for glypican-3 peptide vaccine therapy response in ovarian clear cell carcinoma
    Ukai, Mayu
    CANCER SCIENCE, 2022, 113 : 696 - 696
  • [36] Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis
    Wang, Yichen
    Yang, Huayu
    Xu, Haifeng
    Lu, Xin
    Sang, Xinting
    Zhong, Shouxian
    Huang, Jiefu
    Mao, Yilei
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (03) : 597 - 602
  • [37] Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma
    Wang, Li
    Pan, Liuhong
    Yao, Min
    Cai, Yin
    Dong, Zhizhen
    Yao, Dengfu
    ONCOTARGET, 2016, 7 (27) : 42150 - 42158
  • [38] A NOVEL ONCOFETAL PROTEIN - GLYPICAN 3-CAN BE A TUMOR MARKER FOR PEDIATRIC RENAL TUMORS, INCLUDING NEPHROBLASTOMAS AND CLEAR-CELL SARCOMAS OF THE KIDNEY
    Kodaka, Tetsuro
    Ohta, Satoshi
    Kanamori, Yutaka
    Fukayama, Masashi
    Iwanaka, Tadashi
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 881 - 882
  • [39] Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker
    Nakatsura, T
    Yoshitake, Y
    Senju, S
    Monji, M
    Komori, H
    Motomura, Y
    Hosaka, S
    Beppu, T
    Ishiko, T
    Kamohara, H
    Ashihara, H
    Katagiri, T
    Furukawa, Y
    Fujiyama, S
    Ogawa, M
    Nakamura, Y
    Nishimura, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 306 (01) : 16 - 25
  • [40] Evalution of Glypican-3 amino terminal as a tumor marker for detection of Hepatocellular Carcinoma
    Elsawy, Mohamed M.
    Rostom, Youssry
    Abdelmoety, Amr
    Abdelmoety, Hoda
    FASEB JOURNAL, 2009, 23
12345